New ‘scientific wellness’ strategy could cut chronic illnesses and save money
heath.isbscience.org/2018/09/10/new-scientific-wellness-strategy-could-cut-chronic-illnesses-and-save-money/heath.isbscience.org/2018/09/10/new-scientific-wellness-strategy-could-cut-chronic-illnesses-and-save-money/Recent Articles
-
ISB Builds Digital Platform for COVID-19 Research Study – and Beyond
In a multi-institutional study of a highly infectious disease like COVID-19, paperless consent for study participants is critical. One component of the COVID-19 Immune Response Study is a recruitment website with an IRB-approved and HIPAA-compliant electronic consent platform for enrolling patients.
-
For Cancer Cells, There Is More Than One Path to Drug Resistance
In findings published in the journal Nature Communications, researchers show that cancer cells can take more than one path to reach a drug-resistant cell state. These findings could have promising implications for the future of cancer care.
-
Merck and ISB Collaborate to Understand and Treat SARS-CoV-2 Infection
Merck is collaborating with ISB and its partners to analyze blood samples and nasal swabs from Swedish Medical Center patients with SARS-CoV-2. Blood samples will be examined using proteomic, metabolomic, transcriptomics and genetic techniques to evaluate the impact of infection on different organs, and to identify potential biomarkers to predict the risk of severe disease.